[1]
“Stability Indicating RP-UPLC Method Development Validation and Dissolution Testing of Semaglutide ”, Journal of Pharmaceutical Negative Results, vol. 13, no. 4, pp. 1459–1464, Dec. 2022, doi: 10.47750/pnr.2022.13.04.205.